Novo Holdings Overview
Novo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. It serves as the controlling shareholder of Novo Nordisk A/S and Novonesis A/S, and manages a diversified investment portfolio with a long-term return perspective. The company invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure, and private equity assets.
Is Novo Holdings the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Novo Holdings, along with a list of other relevant VCs, is available on Hopohopo.io.
Novo Holdings
Investment focus
Product type
- Software
- Services
- Materials
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
DKK 50,000,000 - DKK 125,000,000
How to approach funds like Novo Holdings
When engaging Novo Holdings, founders should highlight how their innovation addresses significant unmet needs in life sciences or healthcare, with a clear path to scalable impact. Demonstrating robust scientific validation, a credible team with sector expertise, and a vision for long-term value creation will resonate. Novo Holdings values strategic alignment with their commitment to advancing health and sustainability, so emphasize how your solution fits within these broader goals and can thrive in a global context.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
